Harlan Robins
Harlan Robins is Chief Scientific Officer at Adaptive Biotechnologies.
Temporal rises to No. 1 on GeekWire 200 after $550M raise at $12.55B valuation as AI and hardware firms climb
Temporal is now the No. 1 company on the GeekWire 200 after a $550 million raise valuing it at $12.55 billion and surpassing $250 million in annualized revenue; the Fall 2026 ranking highlights growth in AI software and advanced machinery for space, energy and defense across the Pacific Northwest.
Harell Data founded by Harlan Robins raises $15M to let data owners securely monetize AI training
Harlan Robins, co-founder and former CSO of Adaptive Biotechnologies, launched Harell Data with $15 million in funding to let proprietary data owners securely host datasets for AI model training and receive direct revenue shares instead of waiting for downstream royalties.
Adaptive Biotechnologies’ Spinout Digital Biotechnologies Raises $15M Series A to Develop Clinical DNA Sequencing Instrument
Digital Biotechnologies, a Seattle-based subsidiary of Adaptive Biotechnologies, has raised up to $15 million in a Series A round to develop a novel clinical DNA sequencing technology. Adaptive will retain nearly half ownership as Digital Biotechnologies aims to create a high-accuracy, rapid, low-cost sequencing instrument for clinical use.
Inside the IPO: Adaptive Biotech
Chad Robins is a Cornell grad and Wharton School MBA who was working in real estate finance a decade ago when he was approached with a business idea by his brother, Harlan Robins, head of the Computational Biology Program at the Fred Hutchinson Cancer Research Center. As Chad Robins recalled, "When he called me up in 2009 and said, 'Hey I want to start a business, I've figured out how to sequence T-cells at a high throughput,' I was like, 'Yes, I'm in!' and then I went to Wikipedia and I'm like, 'What the hell is he talking about?' I…
Organizations
-
Adaptive Biotechnologies Chief Scientific Officer · current
